Journal of Experimental & Clinical Cancer Research

SCI期刊
Journal of Experimental & Clinical Cancer Research
中文名称:
实验与临床癌症研究杂志
期刊缩写:
J. Exp. Clin. Cancer Res.
影响因子:
11.4
ISSN:
print: 1756-9966
on-line: 0392-9078
研究领域:
医学-肿瘤学
创刊年份:
2008年
h-index:
67
自引率:
1.80%
Gold OA文章占比:
99.89%
原创研究文献占比:
83.11%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
The Journal of Experimental & Clinical Cancer Research is an esteemed peer-reviewed publication that focuses on cancer research, encompassing everything from fundamental discoveries to practical applications. We welcome submissions that showcase groundbreaking advancements in the field of cancer research, especially those that bridge the gap between laboratory findings and clinical implementation. Our goal is to foster a deeper understanding of cancer, improve prevention and detection strategies, facilitate accurate diagnosis, and enhance treatment options. We are particularly interested in manuscripts that shed light on the mechanisms behind the development and progression of cancer, including metastasis. Additionally, we encourage submissions that explore molecular alterations or biomarkers that can help predict the efficacy of different treatments or identify drug resistance. Translational research related to targeted therapies, personalized medicine, tumor immunotherapy, and innovative approaches applicable to clinical investigations are also of great interest to us. We provide a platform for the dissemination of large-scale molecular characterizations of human tumors and encourage researchers to share their insights, discoveries, and methodologies with the wider scientific community. By publishing high-quality research articles, reviews, and commentaries, the Journal of Experimental & Clinical Cancer Research strives to contribute to the continuous improvement of cancer care and make a meaningful impact on patients' lives.
期刊介绍中文:
Journal of Experimental & Clinical Cancer Research是一个备受推崇的同行评审刊物,专注于癌症研究,涵盖从基础发现到实际应用的方方面面。本刊热情欢迎揭示癌症发展和恶化机制的稿件,特别关注弥合实验室研究与临床应用之间的差距。我们的目标是深化对癌症的理解,改进预防和检测策略,推动准确诊断和治疗方案的改进。我们鼓励投稿探讨预测不同疗法疗效或识别耐药性的分子改变或生物标志物,以及与靶向治疗、个性化医疗、肿瘤免疫疗法和创新临床研究方法相关的转化研究。此外,该刊提供了传播人类肿瘤分子特征的平台,鼓励研究人员分享他们的见解、发现和方法。通过发表高质量的研究文章、综述和评论,致力于提升癌症研究水平。
CiteScore:
CiteScoreSJRSNIPCiteScore排名
18.22.8061.770
学科
排名
百分位
大类:Medicine
小类:Oncology
23 / 404
94%
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
16 / 230
93%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
1区 医学
2区 肿瘤学 ONCOLOGY
WOS期刊分区
学科分类
Q1ONCOLOGY
历年影响因子
2015年4.3570
2016年5.1890
2017年6.2170
2018年5.6460
2019年7.0680
2020年11.1610
2021年12.6580
2022年11.3000
2023年11.4000
历年发表
2012年104
2013年106
2014年162
2015年159
2016年195
2017年194
2018年327
2019年506
2020年288
2021年406
2022年333
投稿信息
出版周期:
Quarterly
出版语言:
English
出版国家(地区):
ITALY
审稿时长:
1 months
论文处理费:
Free
出版商:
BioMed Central
编辑部地址:
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Journal of Experimental & Clinical Cancer Research - 最新文献

Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors.

Pub Date : 2024-11-06 DOI: 10.1186/s13046-024-03219-0 Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, Santeri A Pakola, Tatiana Kudling, Victor Arias, Lyna Haybout, Katriina Jalkanen, Tuomo Alanko, Tine Monberg, Amir Khammari, Brigitte Dreno, Inge Marie Svane, Matthew S Block, Daniel A Adamo, Johanna Mäenpää, Claudia Kistler, Suvi Sorsa, Otto Hemminki, Anna Kanerva, João M Santos, Victor Cervera-Carrascon, Akseli Hemminki

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.

Pub Date : 2024-11-05 DOI: 10.1186/s13046-024-03213-6 Maria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, Paola Verachi, Massimo Zucchetti, Cristina Matteo, Elena Petricci, Emanuela Pilozzi, Isabella Orienti, Alessandra Boe, Adriana Eramo, Rachele Rossi, Tiberio Corati, Daniele Macchia, Anna Maria Pacca, Ann Zeuner, Marta Baiocchi

Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.

Pub Date : 2024-11-04 DOI: 10.1186/s13046-024-03214-5 Juliano Tiburcio de Freitas, Varsha Thakur, Kathryn M LaPorte, Vijay S Thakur, Brian Flores, Valentina Caicedo, Chioma G E Ajaegbu, Giuseppe Ingrasci, Zoe M Lipman, Keman Zhang, Hong Qiu, Thomas R Malek, Barbara Bedogni
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信